HR 3206 · 112th Congress 2011โ€“2013, ended

Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011

Latest action · Oct 18, 2011 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedOct 14, 2011
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act to revise provisions related to financial interests of Food and Drug Administration (FDA) advisory committee members to require the Secretary of Health and Human Services (HHS) to ensure that individual appointments to advisory committees are made to promote scientific and technical expertise while at the same time minimizing any potential conflicts of interest. Requires the Secretary to consider, with respect to any financial interest constituting a potential conflict of interest, the type, nature, and magnitude of the financial interest. Declares that no specific factor shall be dispositive in the Secretary's evaluation of a particular financial interest.

Repeals the prohibition specifically applicable to FDA that prevents a member of an advisory committee from participating with respect to a particular matter if such individual or an immediate family member of such individual has a financial interest that could be affected by the advice given to the Secretary.

Cosponsors 15

Members who signed on, in the order they did. Signatures ran from Oct 14, 2011 to Jan 31, 2012; 8 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-LABill CassidyOriginalOct 14, 2011
R-KYBrett GuthrieOriginalOct 14, 2011
R-CABrian P. BilbrayOriginalOct 14, 2011
R-MNErik PaulsenOriginalOct 14, 2011
R-ILJohn ShimkusOriginalOct 14, 2011
R-TNMarsha BlackburnOriginalOct 14, 2011
R-GAPhil GingreyOriginalOct 14, 2011
R-OHRobert E. LattaOriginalOct 14, 2011
R-TXJohn Abney CulbersonOct 27, 2011
R-ORGreg WaldenNov 3, 2011
R-INLarry BucshonDec 13, 2011
R-TXMichael T. McCaulDec 16, 2011
R-INTodd RokitaJan 24, 2012
D-UTJim MathesonJan 31, 2012
D-GAJohn BarrowJan 31, 2012

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Oct 14, 2011
Health Subcommittee
Referred Oct 18, 2011

Actions 3

Everything that happened, newest first.

  1. Oct 18, 2011Referred to the Subcommittee on Health.
  2. Oct 14, 2011Introduced in House
  3. Oct 14, 2011Referred to the House Committee on Energy and Commerce.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article 1 Section 8 Clause 3 which states that Congress has the authority ``To regulate Commerce with foreign Nations, and among the several States, and with the Indian Tribes;''

The sponsor’s statement, as printed in the page H6977.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Federal Food, Drug, and Cosmetic Act with respect to appointments to advisory committees and conflicts of interest.
Short Titles as Introduced
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Oct 14, 2011Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.